1,176 results match your criteria: "Nagano Red Cross Hospital; T. Fujibayashi[Affiliation]"

Introduction: Combination therapy of anti-programmed cell death 1 (PD-1)/programmed cell death ligand 1 (PD-L1) antibodies and platinum-based chemotherapy has been widely used as a first-line treatment for patients with unresectable advanced non-small cell lung cancer (NSCLC) in clinical settings; however, prognostic biomarkers associated with survival outcomes have not been sufficiently investigated.

Methods: We enrolled 147 previously untreated patients with advanced NSCLC who were treated with a combination therapy of anti-PD-1/-PD-L1 antibodies and platinum-based chemotherapy at eight institutions in Nagano Prefecture between December 2018 and April 2023. We evaluated the prognostic value of the geriatric nutritional risk index (GNRI), a systemic inflammatory nutritional biomarker calculated from body weight and serum albumin level, for patients with NSCLC treated with a combination therapy of anti-PD-1/-PD-L1 antibodies and platinum-based chemotherapy.

View Article and Find Full Text PDF

The Epstein-Barr virus (EBV) is associated with many malignancies and autoimmune diseases, including multiple sclerosis. In addition, EBV rarely but occasionally causes central nervous system (CNS) complications. We herein report a case of transverse myelitis (TM) associated with systemic EBV reactivation after herpes zoster infection in a cord blood transplant recipient.

View Article and Find Full Text PDF

Background: Acute asthma exacerbation in children is often caused by respiratory infections. In this study, a coordinated national surveillance system for acute asthma hospitalizations and causative respiratory infections was established. We herein report recent trends in pediatric acute asthma hospitalizations since the COVID-19 pandemic in Japan.

View Article and Find Full Text PDF

Background: Allergic bronchopulmonary mycosis (ABPM) is an allergic disease caused by type I and type III hypersensitivity to environmental fungi. Schizophyllum commune, a basidiomycete fungus, is one of the most common fungi that causes non-Aspergillus ABPM.

Objective: Herein, we attempted to clarify the clinical characteristics of ABPM caused by S.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates how new antirheumatic drugs affect the characteristics of lymphoproliferative disorder (LPD) in rheumatoid arthritis (RA) patients, using data from 53 hospitals in Japan between 1999 and 2021.
  • A total of 752 patients with RA-associated LPD were compared to 770 with sporadic LPD, revealing notable differences in their clinical features and the impact of various drug combinations.
  • The findings suggest that medications taken before LPD onset may alter its characteristics, and recommend tocilizumab (TCZ) as a better treatment option after LPD has developed.
View Article and Find Full Text PDF

Background: Data concerning the use of lenvatinib in very old patients (≥ 80 years) are limited, although the incidence of hepatocellular carcinoma (HCC) in this patient population is constantly increasing.

Objective: This analysis aimed to evaluate the efficacy and safety of lenvatinib in a large cohort of very old patients (≥ 80 years) with unresectable HCC.

Patients And Methods: The study was conducted on a cohort of 1325 patients from 46 centers in four Western and Eastern countries (Italy, Germany, Japan, and the Republic of Korea) who were undergoing first-line treatment with lenvatinib between July 2010 and February 2022.

View Article and Find Full Text PDF

I am keenly interested in ultrasound diagnosis of the invasion depth of gallbladder carcinoma (GBC) [...

View Article and Find Full Text PDF

Background: Rechallenge therapy with epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) is known to confer some clinical benefit for patients with metastatic EGFR-mutated non-small cell lung cancer (NSCLC). However, little is known about the efficacy of EGFR-TKI rechallenge after resistance to first-line (1L) osimertinib. This study aimed to assess the efficacy and safety of EGFR-TKI rechallenge therapy after resistance to 1L osimertinib in a Japanese clinical setting.

View Article and Find Full Text PDF
Article Synopsis
  • Patients in ICUs need effective palliative care to relieve suffering, leading to a study focused on creating and testing quality indicators (QIs) for such care using expert consensus and EMR data.
  • The study developed a set of 28 quality indicators based on expert input, despite some items being less measurable but still deemed important for holistic care.
  • Pilot testing showed the feasibility of these QIs, revealing variability in care performance and highlighting areas needing improvement, such as pain management, advance care planning, family involvement, and psychological support for families.
View Article and Find Full Text PDF

Background: The present study aimed to investigate prescription patterns for patients aged over 17 years with headaches in the REZULT database.

Methods: We conducted a cross-sectional study (Study 1) of the proportion of over-prescription of acute medications (≥30 tablets/90 days for triptans, combination non-steroidal anti-inflammatory drugs (NSAIDs) and multiple types; ≥45 tablets/90 days for single NSAIDs) among patients with headache diagnosed in 2020. We longitudinally studied (Study 2) patients for >2 years from initial headache diagnosis (July 2010 to April 2022).

View Article and Find Full Text PDF
Article Synopsis
  • Fludarabine-based conditioning regimens in cord blood transplantation (CBT) have varying effectiveness, with the study analyzing five different combinations in 1395 adult patients suffering from myeloid malignancies.
  • The results showed that the combination of fludarabine and melphalan with high-dose total body irradiation (FM140T) had the highest 3-year survival rate (67%), while other regimens had significantly lower rates, indicating FM140T as the most favorable option.
  • These outcomes suggest that survival rates in CBT for myeloid cancers depend greatly on the type and dosage of alkylating agents used alongside fludarabine, with FM140T being recommended over fludarabine/busulfan
View Article and Find Full Text PDF

A prospective cohort study of periostin as a serum biomarker in patients with idiopathic pulmonary fibrosis treated with nintedanib.

Sci Rep

December 2023

Division of Respirology, Neurology, and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine, 67 Asahi-machi, Kurume, Fukuoka, 830-0011, Japan.

Article Synopsis
  • This study looked at a protein called periostin to see if it could help doctors predict how well patients with a lung disease called idiopathic pulmonary fibrosis (IPF) would do after treatment with a drug named nintedanib.
  • Researchers measured different levels of periostin in 87 patients and compared them to 43 other patients who hadn't been treated with antifibrotic drugs before.
  • They found that higher levels of periostin were linked to better chances of survival and more effectiveness of nintedanib in treating IPF, which might help doctors make better treatment plans in the future.
View Article and Find Full Text PDF

The post-acute sequelae of SARS-CoV-2 (PASC) pose a threat to patients' health-related quality of life (HRQOL). Here, the impact of COVID-19 on HRQOL and the clinical factors associated with impaired HRQOL were examined. Discharged COVID-19 patients were assessed at 3 and 6 months after disease onset.

View Article and Find Full Text PDF

Recent advances in the treatment strategy for AAV improved outcomes with intensive GC tapering.

Int J Rheum Dis

January 2024

Department of Clinical Immunology and Rheumatology/Infectious Disease, Kyushu University Hospital, Fukuoka, Japan.

Article Synopsis
  • - The study aimed to assess care trends for patients with ANCA-associated vasculitis (AAV) over a decade, focusing on two specific types: granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA).
  • - Researchers compared patients treated in two different timeframes (early vs. late) and found that the late group used more rituximab (RTX) and required lower doses of glucocorticoids (GC), resulting in better remission rates and fewer complications.
  • - The findings suggest that advancements in treatment strategies for AAV have led to improved patient outcomes, including effective disease management and reduced reliance on glucocorticoids over time.
View Article and Find Full Text PDF

Ongoing impacts of childhood-onset glomerular diseases during young adulthood.

Pediatr Nephrol

June 2024

Department of Pediatrics, Faculty of Life Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto City, 860-8556, Japan.

Background: Childhood-onset glomerular disease often requires ongoing treatment and follow-up into adulthood. However, few studies have analyzed the associated impact and distress experienced by patients with this condition during the transition from childhood to adolescence and adulthood.

Methods: At three facilities, we recruited patients who developed idiopathic nephrotic syndrome or IgA nephropathy during childhood and were at least 18 years old at the time of study entry.

View Article and Find Full Text PDF

Opsoclonus-myoclonus syndrome (OMS) is a rare neurological disorder characterized by myoclonus, ataxia, and tremors. It can be classified as neoplastic or idiopathic, with small cell lung cancer being commonly associated. Herein, we present a rare case of refractory paraneoplastic neurological syndrome (PNS) caused by large cell neuroendocrine carcinoma (LCNEC), a rare form of non-small cell lung cancer (NSCLC).

View Article and Find Full Text PDF
Article Synopsis
  • - Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is an effective treatment for diffuse large B-cell lymphoma (DLBCL) due to its graft-versus-lymphoma effect, but identifying which patients will benefit is challenging.
  • - Analysis of 1,268 DLBCL patients showed 3-year overall survival and progression-free survival rates at 30.3% and 21.6%, respectively, with various factors impacting patient outcomes post-transplantation.
  • - A prognostic index was developed based on four key factors that predict different 3-year progression-free survival rates, aiding in identifying patients who might benefit from allo-HSCT, though its applicability to post-chimeric
View Article and Find Full Text PDF

Background: To investigate the outcome of non-valved glaucoma drainage implant surgery (GDIS) in primary open-angle glaucoma (POAG) patients divided in the first GDI group (patients who underwent the first GDIS) and the second GDI group (patients who underwent the second GDIS because of the failed first GDIS).

Methods: Intraocular pressure (IOP), visual acuity (VA), visual field defect (VFD), medication score (MS), survival rate of GDIS, complications, and patient background was retrospectively analyzed. Two success criteria were set: Criteria (1) IOP reduction ≥ 20% and 5 < IOP ≤ 21, Criteria (2) IOP reduction ≥ 20% and 5 < IOP ≤ 14.

View Article and Find Full Text PDF

We conducted a multicenter, prospective observational study of acute myeloid leukemia (AML), myelodysplastic syndromes (MDS), and chronic myelomonocytic leukemia (CMML) in Japan. From August 2011 to January 2016, we enrolled 6568 patients. Herein, we report the results for MDS (n = 2747) and CMML (n = 182).

View Article and Find Full Text PDF
Article Synopsis
  • - The study aimed to determine if adding self-reported weight loss data enhances the prediction of mortality related to sarcopenia in heart failure patients.
  • - Involving 477 patients with a mean age of 77, they found that 32% had both sarcopenia and reported weight loss, which was linked to a higher mortality rate during a follow-up of about 763 days.
  • - Results indicated that the combination of sarcopenia and self-reported weight loss is a significant independent predictor of mortality, improving the accuracy of mortality risk assessments in heart failure patients.
View Article and Find Full Text PDF

Background: We previously developed a Japan Esophageal Society Barrett's Esophagus (JES-BE) magnifying endoscopic classification for superficial BE-related neoplasms (BERN) and validated it in a nationwide multicenter study that followed a diagnostic flow chart based on mucosal and vascular patterns (MP, VP) with nine diagnostic criteria. Our present post hoc analysis aims to further simplify the diagnostic criteria for superficial BERN.

Methods: We used data from our previous study, including 10 reviewers' assessments for 156 images of high-magnifying narrow-band imaging (HM-NBI) (67 dysplastic and 89 non-dysplastic histology).

View Article and Find Full Text PDF

Introduction: Necitumumab plus gemcitabine and cisplatin (GCN) is a standard therapy for patients with advanced lung squamous cell carcinoma (LSqCC). However, the efficacy and tolerability of GCN in second-line or later treatment for patients previously treated with immune checkpoint inhibitors (ICIs) remain unknown.

Methods: This multicenter, retrospective, cohort study assessed the efficacy and tolerability of GCN initiated between November 1, 2019 and March 31, 2022 as second-line to fourth-line treatment in patients with advanced LSqCC who had been pretreated with ICIs.

View Article and Find Full Text PDF

Alice in Wonderland syndrome (AIWS) is extremely rare, occurring more often in young individuals than in older adults. Symptoms of this syndrome typically include an altered body image, size perception, and time perception. However, the pathophysiology and lesions responsible for this syndrome remain unclear.

View Article and Find Full Text PDF